Welcome to the third edition in the EPA Webinar Series 2025. This 90-minute webinar will take place on Monday, 27 October, from 16:00 to 18:00 CET.
Major depressive disorder (MDD) affects over 300
million people worldwide. The so-called treatment-resistant depression (TRD)
represents a subgroup of this condition, but inconsistent international
definitions make it difficult to estimate its exact prevalence.
This webinar will enable the attendees to gain
knowledge on the evidence-based diagnostics and treatment of the so-called TRD.
Besides the introduction of the clinical phenotype of TRD, a detailed
information will be provided for the approved as well as experimental
pharmacological and non-pharmacological treatment strategies, as well as their
best possibly effective and safe use in TRD according to the recommended
therapeutic algorithms.
For any question, please contact Simone De Ioanna (simone.deioanna@europsy.net) in advance of the webinar.
You are welcome to share this free & open webinar with your colleagues, students, and peers!